Skip to main content

Table 1 One-, three-, and five-year cumulative incidence of mortality in stage I SCLC patients

From: Nomogram model for predicting cause-specific mortality in patients with stage I small-cell lung cancer: a competing risk analysis

Characteristics

N

%

Event

%

Cancer-specific death

Death from other causes

1-year (%)

3-year (%)

5-year (%)

P

1-year (%)

3-year (%)

5-year (%)

P

Total

1811

 

1221

 

28.7

56.5

61.5

 

5.8

11.1

13.6

 

Age at diagnosis

       

< 0.001

   

0.001

  < 60 years

342

18.9

192

15.7

18.6

49.8

53.1

 

5.2

7.7

8.2

 

 60–75 years

981

54.2

640

52.4

26.1

53.5

59.5

 

5.5

10.7

14.3

 

  > 75 years

488

26.9

389

31.9

40.9

67.1

71.4

 

6.9

14.2

15.9

 

Gender

       

0.574

   

0.016

 Female

949

52.4

619

50.7

27.3

56.3

60.5

 

5.1

9.1

11.3

 

 Male

862

47.6

602

49.3

30.1

56.7

62.6

 

6.5

13.3

16.0

 

Race

       

0.690

   

0.183

 White

1578

87.1

1064

87.1

28.9

56.1

60.8

 

5.9

11.3

13.8

 

 Black

167

9.2

111

9.1

26.4

57.9

66.0

 

5.7

7.8

9.9

 

 Others

66

3.7

46

3.8

27.7

64.3

66.6

 

3.3

15.1

17.4

 

Anatomic sites

       

< 0.001

   

0.048

 Upper

1025

56.6

685

56.1

26.5

55.9

60.6

 

5.6

11.8

14.5

 

 Middle

115

6.4

76

6.2

22.7

51.6

55.1

 

12.5

19.8

19.8

 

 Lower

505

27.9

336

27.5

29.4

55.7

61.8

 

5.1

8.0

11.1

 

 Bronchus/others

166

9.2

124

10.2

43.6

66.0

70.5

 

4.5

9.9

10.8

 

Primary tumor location

       

0.221

   

0.682

 Left-sided

793

43.8

522

42.8

28.1

55.3

59.8

 

6.2

12.0

14.1

 

 Right-sided

1018

56.2

699

57.2

29.1

57.4

62.8

 

5.5

10.4

13.1

 

Tumor size

       

< 0.001

   

0.030

  ≤ 3 cm

967

53.4

602

49.3

23.7

50.6

55.0

 

5.7

12.1

15.7

 

 3–5 cm

523

28.9

379

31.0

30.5

59.6

66.1

 

7.1

10.9

12.1

 

> 5 cm

321

17.7

240

19.7

40.5

68.8

73.3

 

3.9

8.5

9.5

 

Tumor extension

       

< 0.001

   

0.005

 Local

1526

84.3

1020

83.5

27.9

55.4

59.7

 

6.3

11.8

14.6

 

 Regional

285

15.7

201

16.5

32.5

62.2

71.3

 

3.3

7.3

8.0

 

Grading

       

0.038

   

0.375

 Good or moderate

34

1.9

18

1.5

16.3

36.6

41.3

 

3.1

6.8

16.7

 

 Poor

343

18.9

207

17.0

26.3

51.3

54.1

 

4.9

11.8

13.3

 

 Undifferentiated

439

24.2

318

26.0

26.5

58.0

65.0

 

5.6

8.4

11.6

 

 NOS

995

54.9

678

55.5

30.8

58.1

62.9

 

6.3

12.3

14.5

 

Surgery

       

< 0.001

   

0.593

 Yes

457

25.2

214

17.5

11.2

35.6

40.4

 

4.6

9.5

12.0

 

 No

1354

74.8

1007

82.5

34.5

63.4

68.5

 

6.2

11.6

14.1

 

Chemotherapy

       

< 0.001

   

< 0.001

 Yes

1217

67.2

783

64.1

23.8

54.0

60.0

 

3.6

8.6

11.2

 

 No

594

32.8

438

35.9

38.7

61.8

64.6

 

10.4

16.3

18.6

 

Radiotherapy

       

< 0.001

   

0.773

 Yes

929

51.3

595

48.7

21.7

52.1

58.8

 

4.1

10.3

13.3

 

 No

882

48.7

626

51.3

36.0

61.2

64.4

 

7.6

12.0

13.8

Â